Novavax, Inc. - Common Stock (NVAX)

$7.34 0.17 (2.37%)

11:01 EST NVAX Stock Quote Delayed 30 Minutes

7 Very Oversold Nasdaq Stocks to Buy Right Now

By Larry Ramer, InvestorPlace Contributor Aug 23, 2023

The worries that have pushed the Nasdaq down sharply are overdone. Here are seven oversold Nasdaq stocks poised to rebound.

Novavax (NVAX) Stock Is Getting Ready to Rally Again

Why Is Novavax (NVAX) Stock Up 15% Today?

3 Biotech Stocks to Sell in August Before They Crash and Burn

Volume:

Previous Close -

Market Cap 546.71M

PE Ratio -3.21

EPS -2.29

Volume (Avg. Vol.) 1.14M

Day's Range $7.17 - $7.42

52-Week Range $3.81 - $23.86

Dividend & Yield N/A (N/A)

NVAX Stock Predictions, Articles, and Novavax, Inc. - Common Stock News

Danger! These 3 Growth Stocks Are a Definite No-Go for Investors.

By Chris MacDonald, InvestorPlace Contributor Aug 10, 2023

These three growth stocks may appear to be intriguing speculative bets at current levels, but don't be fooled.

3 Healthcare Stocks to Sell in August Before They Crash and Burn

By Joel Baglole, InvestorPlace Contributor Aug 9, 2023

Steer clear of these healthcare stocks, each of which is struggling with significant problems that are impacting their earnings.

Novavax (NVAX) Stock Gets a Boost From Q2 Vaccine Sales

By William White, InvestorPlace Writer Aug 8, 2023

Novavax (NVAX) stock is climbing higher on Tuesday after the vaccine company released earnings results for the second quarter of the year.

Looking for a Bargain? 3 Biotech Stocks to Buy That Are Down 20%-60% in 2023

By Larry Ramer, InvestorPlace Contributor Aug 1, 2023

Since the pharmaceutical sector is very lucrative in America, these biotech stock bargains can be very profitable.

7 Biotech Stocks to Sell in July

By Thomas Niel, InvestorPlace Contributor Jul 13, 2023

Running the gamut from large to small, and from commercial stage to clinical stage, these are seven top biotech stocks to sell in July.

Why Is Novavax (NVAX) Up 30% Today?

By Josh Enomoto, InvestorPlace Contributor Jul 10, 2023

While Novavax secured an agreement with the Canadian government over unused Covid-19 vaccines, NVAX stock remains risky.

Get Out Now! 3 Stocks to Dump Before the Short-Selling Ban.

By Alex Sirois, InvestorPlace Contributor Jun 28, 2023

Any future short-selling ban will severely affect these stocks, potentially leaving many investors who don't sell in deep trouble.

3 Pharma Stocks That Have Big Investors Running for the Exit

By Joel Baglole, InvestorPlace Contributor Jun 28, 2023

Hedge funds, institutional investors and company insiders have been dumping shares of these risky pharma stocks.

Exit Strategy: Get Out of These 3 Poor-Performing Stocks Now

By Joel Baglole, InvestorPlace Contributor Jun 16, 2023

Avoiding bad investments is just as important as spotting good opportunities, so watch out for these stocks to sell now.

7 High-Risk, High-Reward Stocks to Buy in June

By Larry Ramer, InvestorPlace Contributor Jun 12, 2023

These are the best high-risk, high-reward stocks to buy in June. They can all generate big profits for investors.

3 Biotech Stocks to Sell in June Before They Crash and Burn

By Joel Baglole, InvestorPlace Contributor Jun 6, 2023

The biotechnology sector has seen better days. From the Hedy days of the pandemic when companies were racing to develop a vaccine against Covid-19, the industry is now enduring a hangover as both demand and sales decline.

7 F-Rated Stocks to Sell in June

By Louis Navellier and the InvestorPlace Research Staff Jun 2, 2023

As summer arrives, this is a good time for a quick portfolio evaluation and weed out those names that are most likely to underperform.

The 3 Best Stocks to Short in May 2023

By Will Ashworth, InvestorPlace Contributor May 19, 2023

The best stocks to short are companies whose businesses aren’t faring well and have a higher-than-average short interest.

Artificial Intelligence Engine Predicts NVAX Stock to Gain 7% by June 15

By Keith Kaplan and TradeSmith Research Staff May 18, 2023

Watch our new video to find out how you can get 3,000 more predictions just like this

Short-Squeeze Stocks Alert: CVNA, NVAX Make Most-Shorted Stocks List

By Josh Enomoto, InvestorPlace Contributor May 11, 2023

Business news outlet CNBC recently posted its list of top short-squeeze stocks, which present potentially lucrative though risky ideas.

Novavax Layoffs 2023: What to Know About the Latest NVAX Job Cuts

By William White, InvestorPlace Writer May 9, 2023

Novavax (NVAX) layoffs are on the way as the vaccine maker revealed plans to cut a large portion of its workforce on Tuesday!

NVAX Stock Earnings: Novavax Beats EPS, Misses Revenue Estimates

By Sarah Smith, Editor-in-Chief, InvestorPlace.com May 9, 2023

NVAX stock earnings show that Novavax reported a narrower loss than expected but missed revenue estimates for Q1.

7 Short-Squeeze Stocks That Are Breaking All the Rules

By Josh Enomoto, InvestorPlace Contributor Apr 20, 2023

Although the bears have every reason to cynically target these troubled enterprises, they vexingly represent short-squeeze stocks.

7 Short-Squeeze Stocks That Are Driving Hedge Funds Crazy

By Josh Enomoto, InvestorPlace Contributor Apr 16, 2023

Although market bears seem to have the right idea with these short-squeeze stocks, the bulls continue to frustrate them.

7 Sorry Pharma Stocks to Sell in April Before It’s Too Late

By Louis Navellier and the InvestorPlace Research Staff Apr 16, 2023

You have to be patient when investing in pharma stocks. But sometimes the risk and the wait aren't worth the rewards.

Novavax, Inc. - Common Stock (NVAX)

7 Very Oversold Nasdaq Stocks to Buy Right Now

Novavax (NVAX) Stock Is Getting Ready to Rally Again

Why Is Novavax (NVAX) Stock Up 15% Today?

3 Biotech Stocks to Sell in August Before They Crash and Burn

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

Novavax, Inc. - Common Stock (NVAX)

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

NVAX Stock Predictions, Articles, and Novavax, Inc. - Common Stock News

Subscriber Sign in